The natural product carolacton inhibits folate-dependent C1 metabolism by targeting FolD/MTHFD
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The natural product carolacton inhibits folate-dependent C1 metabolism by targeting FolD/MTHFD
Authors
Keywords
-
Journal
Nature Communications
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-10
DOI
10.1038/s41467-017-01671-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Isolation, Structure Elucidation, and (Bio)Synthesis of Haprolid, a Cell-Type-Specific Myxobacterial Cytotoxin
- (2016) Heinrich Steinmetz et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Crystal Structure of the Emerging Cancer Target MTHFD2 in Complex with a Substrate-Based Inhibitor
- (2016) Robert Gustafsson et al. CANCER RESEARCH
- The biofilm inhibitor Carolacton inhibits planktonic growth of virulent pneumococci via a conserved target
- (2016) Jannik Donner et al. Scientific Reports
- Impact of Mutating the Key Residues of a Bifunctional 5,10-Methylenetetrahydrofolate Dehydrogenase-Cyclohydrolase from Escherichia coli on Its Activities
- (2015) Shivjee Sah et al. BIOCHEMISTRY
- Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity
- (2015) Thomas C. Eadsforth et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug Development
- (2015) P. M. Tedeschi et al. MOLECULAR CANCER RESEARCH
- One-Carbon Metabolic Pathway Rewiring in Escherichia coli Reveals an Evolutionary Advantage of 10-Formyltetrahydrofolate Synthetase (Fhs) in Survival under Hypoxia
- (2014) Shivjee Sah et al. JOURNAL OF BACTERIOLOGY
- Natural products: A continuing source of novel drug leads
- (2013) Gordon M. Cragg et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data
- (2012) M. Kearse et al. BIOINFORMATICS
- Acinetobacter baumanniiFolD ligand complexes - potent inhibitors of folate metabolism and a re-evaluation of the structure of LY374571
- (2012) Thomas C. Eadsforth et al. FEBS Journal
- Assessment of Pseudomonas aeruginosa N5,N10-Methylenetetrahydrofolate Dehydrogenase - Cyclohydrolase as a Potential Antibacterial Drug Target
- (2012) Thomas C. Eadsforth et al. PLoS One
- LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery
- (2011) Roman A. Laskowski et al. Journal of Chemical Information and Modeling
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Damage of Streptococcus mutans biofilms by carolacton, a secondary metabolite from the myxobacterium Sorangium cellulosum
- (2010) Brigitte Kunze et al. BMC MICROBIOLOGY
- Carolacton - A Macrolide Ketocarbonic Acid that Reduces Biofilm Formation by the Caries- and Endocarditis-Associated BacteriumStreptococcus mutans
- (2010) Rolf Jansen et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- xia2: an expert system for macromolecular crystallography data reduction
- (2009) G. Winter JOURNAL OF APPLIED CRYSTALLOGRAPHY
- A simple and efficient expression and purification system using two newly constructed vectors
- (2008) Huanting Liu et al. PROTEIN EXPRESSION AND PURIFICATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started